[New classes of drugs in the pipeline. New in the treatment of diabetes mellitus].
Steri
Ramona
R
Institut für Pharmazeutische Chemie, Zentrum für Arzneimittelforschung, Entwicklung und Sicherheit, Max-von-Laue-Str. 9, 60438 Frankfurt.
Schubert-Zsilavecz
Manfred
M
D042842:11-beta-Hydroxysteroid Dehydrogenases / Q000037:antagonists & inhibitors; D003920:Diabetes Mellitus / Q000188:drug therapy*; D020536:Enzyme Activators / Q000494:pharmacology / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D051269:Sodium-Glucose Transporter 1 / Q000494:pharmacology / Q000627:therapeutic use
D020536:Enzyme Activators; D004791:Enzyme Inhibitors; D007004:Hypoglycemic Agents; D051269:Sodium-Glucose Transporter 1; D042842:11-beta-Hydroxysteroid Dehydrogenases; D005947:Glucose